Literature DB >> 11297195

Intratumoral microvascular density in malignant lymphomas of B-cell origin.

B Ridell1, K Norrby.   

Abstract

Sections of surgical lymph-node biopsies of four types of malignant non-Hodgkin's lymphoma of B-cell origin (B-NHL) classified according to the R.E.A.L. terminology or lymphadenitis were immunostained in order to demonstrate endothelial CD34 (QBEnd 10) and to determine the microvascular density and vessel-size distribution using an interactive image-analysis technique. Only microvessels displaying a cross-sectional area corresponding to a diameter of between 3.2 and 34.6 microm were included. The intratumoral microvascular density (iMVD) was found to be significantly higher in chronic lymphatic leukaemia (CLL, n = 13) compared with the clinically more aggressive mantle cell lymphoma (MCL, n = 9) and diffuse large B-cell lymphoma (DLBCL, n = 14). iMVD in CLL was also higher than in the follicular neoplastic parts (FL FOLL) of follicular lymphoma (FL, n = 16). In FL FOLL the microvessel density was, moreover, significantly lower than in the surrounding non-neoplastic FL tissue. In lymphadenitis (LA, n = 10) the iMVD was higher than in DLBCL, FL FOLL and MCL. The data suggest that future studies focusing on the relationship between iMVD and the clinical outcome within each particular NHL group should be carried out in order to verify whether iMVD is a prognostic factor in NHL, as it is in carcinomas.

Entities:  

Mesh:

Year:  2001        PMID: 11297195     DOI: 10.1111/j.1600-0463.2001.tb00015.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  9 in total

1.  Angiogenesis in nodal B cell lymphomas: a high throughput study.

Authors:  Alexandar Tzankov; Simone Heiss; Stephanie Ebner; William Sterlacci; Georg Schaefer; Florian Augustin; Michael Fiegl; Stephan Dirnhofer
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

2.  Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases.

Authors:  Pavla Veselá; Zbyněk Tonar; David Sálek; Samuel Vokurka; Marek Trněný; Roman Kodet; Mojmír Moulis; Petra Kašparová; Zdeňka Vernerová; Zuzana Velenská; Jan Stříteský; Michal Michal; Ludmila Boudová
Journal:  Virchows Arch       Date:  2014-07-22       Impact factor: 4.064

Review 3.  The microenvironment in myelodysplastic syndromes: Niche-mediated disease initiation and progression.

Authors:  Allison J Li; Laura M Calvi
Journal:  Exp Hematol       Date:  2017-08-18       Impact factor: 3.084

4.  Angiogenesis in primary central nervous system lymphoma (PCNSL).

Authors:  Hiroaki Takeuchi; Ken Matsuda; Ryuhei Kitai; Kazufumi Sato; Toshihiko Kubota
Journal:  J Neurooncol       Date:  2007-04-04       Impact factor: 4.130

Review 5.  The role of angiogenesis in human non-Hodgkin lymphomas.

Authors:  Domenico Ribatti; Beatrice Nico; Girolamo Ranieri; Giorgina Specchia; Angelo Vacca
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

6.  Increased angiogenesis in cutaneous T-cell lymphomas.

Authors:  Grzegorz Mazur; Zdzisław Woźniak; Tomasz Wróbel; Joanna Maj; Kazimierz Kuliczkowski
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

Review 7.  Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma.

Authors:  Alexandra Ion; Iris Maria Popa; Laura Maria Lucia Papagheorghe; Cristina Lisievici; Mihai Lupu; Vlad Voiculescu; Constantin Caruntu; Daniel Boda
Journal:  Dis Markers       Date:  2016-10-16       Impact factor: 3.434

8.  Histomorphological and Morphometric Evaluation of Microvessel Density in Nodal Non-Hodgkin Lymphoma Using CD34 and CD105.

Authors:  Sant Prakash Kataria; Shivani Malik; Roomi Yadav; Raman Kapil; Rajeev Sen
Journal:  J Lab Physicians       Date:  2021-05-22

9.  Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma.

Authors:  E Passalidou; M Stewart; M Trivella; G Steers; G Pillai; A Dogan; I Leigh; C Hatton; A Harris; K Gatter; F Pezzella
Journal:  Br J Cancer       Date:  2003-02-24       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.